Enhancement of immobility in mouse forced swimming test by treatment with human interferon

被引:45
作者
Makino, M [1 ]
Kitano, Y [1 ]
Hirohashi, M [1 ]
Takasuna, K [1 ]
机构
[1] Daiichi Pharmaceut, Drug Safety Res Lab, Edogawa Ku, Tokyo 1348630, Japan
关键词
interferon; depression; forced swimming test; antidepressant;
D O I
10.1016/S0014-2999(98)00474-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the depression induced by human interferons using the forced swimming test in mice. Intravenous (i.v.) administration of interferon-alpha s (natural interferon-alpha, recombinant interferon-alpha-2a and recombinant interferon-alpha-2b, 600-60 000 IU/kg) increased the immobility time in the forced swimming test in a dose-dependent manner, but natural interferon-beta and recombinant interferon-gamma-1a did not affect the immobility time. The increase in the immobility time induced by recombinant interferon-alpha-2b peaked at 15 min after dosing. Administration of recombinant interferon-alpha-2b (6000 IU/kg, i.v.) once daily for 7 consecutive days increased the immobility time, but natural interferon-beta and recombinant interferon-gamma-1a did not. Recombinant interferon-alpha-2b in combination with the anti-depressants imipramine (10 mg/kg, i.p.) and mianserin (20 mg/kg, i.p.) did not increase the immobility time. These results suggest that interferon-alpha has a greater potential for inducing depression than interferon-beta and -gamma, and that anti-depressants are effective against interferon-alpha-induced depression. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 35 条
  • [31] NEUROLOGICAL EFFECTS OF RECOMBINANT HUMAN INTERFERON
    SMEDLEY, H
    KATRAK, M
    SIKORA, K
    WHEELER, T
    [J]. BRITISH MEDICAL JOURNAL, 1983, 286 (6361) : 262 - 264
  • [32] ELECTROENCEPHALOGRAPHIC ABNORMALITIES IN INTERFERON ENCEPHALOPATHY - A PRELIMINARY-REPORT
    SUTER, CC
    WESTMORELAND, BF
    SHARBROUGH, FW
    HERMANN, RC
    [J]. MAYO CLINIC PROCEEDINGS, 1984, 59 (12) : 847 - 850
  • [33] TAKAGI S, 1995, SEISHIN IGAKU, V37, P344
  • [34] CLINICAL TOXICITY OF THE INTERFERONS
    VIAL, T
    DESCOTES, J
    [J]. DRUG SAFETY, 1994, 10 (02) : 115 - 150
  • [35] THE VALIDITY OF ANIMAL-MODELS OF DEPRESSION
    WILLNER, P
    [J]. PSYCHOPHARMACOLOGY, 1984, 83 (01) : 1 - 16